The present invention concerns a new method of preparing granules comprising 5-aminosalicylic acid and a new method of preparing a pharmaceutical composition for the treatment of ulcerative colitis or
Ulcerative colitis (UC) and Crohn’s disease (CD) are the two major types of IBD, which collectively affect approximately 6.8 million people globally [1]. Over the last decade, there has been a significant transformation in the management of IBD, with the use of targeted biological therapies ...